Saturday, October 24, 2009

Michael G. Jenson, MS, PA-C, CPP



PROFESSIONAL EXPERIENCE

Oct 2009 to Present Tulsa Integrated Pain Service, Tulsa, Oklahoma

Pain medicine, worker compensation evaluations: Perform daily evaluations accompanied by treatment and referral of chronic pain patients. In office pain management modalities such as trigger point, joint, tendon and SI injections. Manage spinal cord stimulator patients and Post-op patients. Addiction counseling. Scientific writer.

July 2006 to Nov 2009 Pain Care Associates of Oklahoma, Tulsa, Oklahoma

Pain medicine, worker compensation evaluations: Perform daily evaluations accompanied by treatment and referral of chronic pain patients. In office pain management modalities such as trigger point, joint, tendon and SI injections. Manage pain pump and spinal cord stimulator patients. Sub-Investigator, Scientific Writer, Addiction counseling. Research Coordinator.

May 2004 to July 2006 Pain Institute of Tulsa & PETC Research Group Inc., Tulsa, Oklahoma

Pain medicine, worker compensation evaluations: Perform daily evaluations accompanied by treatment and referral of chronic pain patients. In office pain management modalities such as trigger point, joint, tendon and SI injections. Manage pain pump and spinal cord stimulator patients. Sub-Investigator, Scientific Writer, Research Coordinator. Coordinates research and assists with the evaluation and management of research patients. Addiction counseling. Publish scientific writings.

July 2003 to May 2004 Pain Evaluation & Treatment Center, Tulsa, Oklahoma

Pain medicine, addiction counseling, and worker compensation evaluations: Perform daily evaluations accompanied by treatment and referral of chronic pain patients. In office pain management modalities such as trigger point, joint, tendon and SI injections. Addiction counseling. See inpatient pain and rehabilitation patients. Publish scientific writings.

May 2002-July 2003 Tulsa Pain Consultants, Tulsa, Oklahoma

Certified Pain Practitioner: Pain medicine, worker‘s compensation evaluations: Perform daily evaluations accompanied by treatment and referral of chronic pain patients. In office pain management modalities such as trigger point, joint, tendon and SI injections. Manage pain pump and spinal cord stimulator patients. Coordinates research and assists with the evaluation and management of research patients. Publish scientific writings.
Addiction counseling.

March 2000-April 2002 PETC Research Group Inc. and Pain Evaluation & Treatment Center, Tulsa, Oklahoma

Director of research, as well as a sub-investigator, and scientific writer. Pain medicine, worker compensation evaluations: Perform daily evaluations accompanied by treatment and referral of chronic pain patients. In office pain management modalities such as trigger point, joint, tendon and SI injections. Manage pain pump and spinal cord stimulator patients. Coordinates research and assists with the evaluation and management of research patients. Addiction counseling. Publish scientific writings.

May 1995-April 2000 Gilcrease Medical Center, Inc., Tulsa, Oklahoma

Occupational medicine, pain management, worker‘s compensation evaluations, urgent and family medicine. Performed daily evaluations accompanied by treatment and referral of work related injuries. In office pain management modalities such as trigger point, joint, tendon and SI injections. Performed routine and urgent care for family medicine patients.
Addiction counseling.

March 1994-May 1995 Utica Park Clinic (Central), Tulsa, Oklahoma

Outpatient evaluation of urgent work and personal injuries as well as acutely ill internal medicine patients. Performed hospital rounds at Hillcrest Medical Center. Worked through the PROCOMP system.

April 1992-March 1994 FHP Staff HMO, Salt Lake City, Utah

Twenty-four hour urgent care facility, managing 5000 - 8000 cardiac, trauma and orthopedic patients per month.

April 1989-April 1992 VA Medical Center, Muskogee, Oklahoma

Assistant to the Chief of Pulmonology and Intensive Care. Performed inpatient evaluations and procedures on critically ill patients as well as typical outpatient evaluations and procedures.

February 1989-April 1989 WorkMed Central Clinic, Tulsa, Oklahoma

Performed evaluation and treatment procedures for work related injuries. Assisted with establishing the mobile hearing and testing unit.

Feb. 1988-Feb. 1989 Jellico Community Hospital, Jellico, Tennessee

Physician Assistant House Officer for busy multi-specialty clinic. Performed emergent evaluations for seriously ill patients, authorized hospital admissions including writing orders and accomplishing daily hospital rounds.

LICENSURE

Board Certified American Academy of Pain Management

Board Certified National Commission for the Certification of Physician Assistants Certificate Number: #1012707

State of Oklahoma Board of Medical Licensure License #538

MEMBERSHIP

Fellow, American Academy of Pain Management
Fellow, American Academy of Physician Assistants
Fellow, Oklahoma Academy of Physician Assistants
Member, Association of Military Surgeons of the United States

MILITARY EXPERIENCE

July 1983-February 1988 101st Airborne Division, Ft. Campbell, Kentucky

Battalion surgeon for rapid deployment infantry division. Combat, tactical risk and medical intelligence risk assessments. Numerous overseas deployments.

July 1981-July 1983 Army Physician Assistant Course, Ft. Sam Houston, Texas

One-year didactic phase through B.S. Degree program Creighton University College of Medicine. One year FLEX internship at the Blanchfield Army Hospital, Ft. Campbell, Kentucky.

July 1969-July 1981 U.S. Army Medic NCO & U.S. Navy Corpsman

Supervised training, platoon leader, clinic administration and treated patients in a combat and clinical environment.

EDUCATION

* Master of Science, Physical Medicine and Pain Management, University Nebraska Medical Center, Omaha,NE 2002

* Bachelor of Arts, Western Illinois University, Macomb, IL 2001

* Internship (Flex) Blanchfield Army Hospital, Ft. Campbell, KY 1981-1983
Physician Associate, Academy of Health Sciences, Ft. Sam Houston, TX,
Affiliated with Creighton University College of Medicine, Omaha, NE

PUBLICATIONS
1. Jenson M, Woman, 62, With Radiating Back Pain, Grand Rounds, Vol 16:9 September 2006 Page 54-57
2. Jenson M, Sorensen R; Early Use of Regional and Local Anesthesia in a Combat Environment May Prevent the Development of Complex Regional Pain Syndrome in Wounded Combatants, Military Medicine Vol. 171 2006
3. Jenson M, Sorensen R; Use of Lidocaine 5% Patches for Persistent Sacroiliac Joint Dysfunction: A Retrospective Study. Poster presentation 33rd Annual meeting of the American Academy of Physician Assistants. 5-28 to 6-2-05 Orlando, FL
4.Jenson M, Sorensen R, Tiagabine in the Treatment of Complex Regional Pain Syndrome Type I, American Journal of Pain Management. April 2005Vol 15:2, 66-70.
5. Jenson M, Sorensen R; An Open-label Trial of Tiagabine in Patients with Primary Fibromyalgia Syndrome. Poster presentation 21st Annual meeting of the American Academy of Pain Medicine. 2-23 to 2-26-05 Palm Springs, CA
6. Sorensen R, Jenson M; Memantine, a Treatment for Migraine: A Prospective Open Label Trial Poster presentation 21st Annual meeting of the American Academy of Pain Medicine. 2-23 to 2-26-05 Palm Springs, CA
7. Jenson M, Sorensen R, Modafinil for excessive daytime sedation secondary to opiates and adjunctive pain medications: A Case Report. The Pain Clinic October 2004,Vol 6:7 5-8
8. Royal M, Bahktah B, Jenson M, et al; A prospective randomized, double-blinded trial evaluating varying volumes of diluent with botulinum toxin type A in the treatment of refractory myofascial cervicothracic pain. Poster presentation 2nd Joint scientific meeting of the American & Canadian Pain Society. 5-6 to 5-9-04 Vancouver, BC
9. Jenson M, Ward S; Use of the Lidocaine Patch 5% in the Treatment of Costochondritis: A Case Study. Poster presentation 20th Annual meeting of the American Academy of Pain Medicine. 3-3 to 3-7-04 Orlando Florida
10. Christopher, A, Jenson M; Ziprasidone Injectable used for Severe Pre-procedure anxiety: A Case Study. . Poster presentation 20th Annual meeting of the American Academy of Pain Medicine. 3-3 to 3-7-04 Orlando Florida
11. Jenson M, Royal M, Christopher, A; Topiramate for the Treatment of Complex Regional Pain Syndrome: A Retrospective Trial in 18. Poster presentation 20th Annual meeting of the American Academy of Pain Medicine. 3-3 to 3-7-04 Orlando Florida
12. Jenson M, Royal M, Christopher, A; Zonisamide for the Treatment of Neuropathy: An Open Label Trial. Poster presentation 20th Annual meeting of the American Academy of Pain Medicine. 3-3 to 3-7-04 Orlando Florida
13. Jenson M, Ward S; Use of the Lidocaine Patch 5% in the Treatment of Costochondritis: A Case Study. The Pain Clinic May/June 2003,Vol 5:9 15-17
14. Jenson M, Ward S, Hale G; Rofecoxib and Montelukast Sodium as Combination Therapy in Arthritis or Other Rheumatic Conditions: A Case Study. The Pain Clinic May/June 2003,Vol 5:4 22-24
15. Jenson M, Hale G, et al; Oral Transmucosal Fentanyl Citrate Used to Reduce Emergency Room Department Visits in Migraine Patients: A Case Series in Outpatients. Poster Presentation American Headache Society 45th Annual Scientific Meeting in Chicago June 19-22, 2003
16. Jenson M, Hale G, et al; Modafinil for Excessive Daytime Sleepiness Secondary to Chronic Opiate Use: A Case Report Poster Presentation 19th Annual Meeting of the American Academy of Pain Medicine. February 18-23, 2003, New Orleans, Louisiana
17. Jenson M, Hale G, et al; Oral Transmucosal Fentanyl Citrate Used to Reduce Emergency Room Department Visits in Migraine Patients: A Case Series in Outpatients. Poster Presentation 19th Annual Meeting of the American Academy of Pain Medicine. February 18-23, 2003, New Orleans, Louisiana
18. Jenson M; Responsible Prescribing of Opioids and Adjunctive Medications in the Treatment of Pain. The Pain Clinic October 2002,Vol 4:5 28-37
19. Jenson M, Royal M, et al; An Open-label Trial of Oxcarbazepine in Patients with Radiculopathy Refractory to Gabapentin. The Pain Clinic August 2002,Vol 4:4 11-13
20. Jenson M, Royal M, et al; Oxcarbazepine an Effective Treatment of Migraine: A Prospective Open Label Trial. Poster Presentation 44th Annual Scientific Meeting of the American Headache Society June 21-23 2002, Seattle, Washington
21. Ward S, Royal M, Jenson M, et al; Fluoroscopy-guided sacroiliac joint injections with Phenol Ablation for Persistent Sacroiliitis: Poster Presentation A Retrospective Study. American Society of Regional Anesthesia 27th annual meeting April 25-28 2002
22. Jenson M, Royal M, et al; Tiagabine an Effective Treatment of Neuropathic Pain: A Prospective Open Label Trial. Poster Presentation 21st Annual Scientific Meeting of the American Pain Society Mar 14-17 2002, Baltimore, MD
23. Royal M, Bhakta B, Gunyae I, Jenson M, et al; Radiofrequency Neurolysis for Facet Arthropathy: A Retrospective Case Series and Review of the Literature. Pain Practice March 2002, Vol 2:1 47-52
24. Ward S, Royal M, Jenson M, et al; An Open-label Trial of Oxcarbazepine in Patients with Radiculopathy Refractory to Gabapentin. Poster Presentation 21st Annual Scientific Meeting of the American Pain Society Mar 14-17 2002, Baltimore, MD
25. Bhakta B, Royal M, Jenson M, et al; Gabapentin and Levetiracetam in Combination for the Treatment of Neuropathic Pain Poster Presentation 21st Annual Scientific Meeting of the American Pain Society Mar 14-17 2002, Baltimore, MD
26. Jenson M; Trigger Point Injections Using 0.9% Sodium Chloride for Patients with Myofacial Pain Syndrome. The Pain Clinic. April 2002 Vol4:2, 26-28
27. Movva V, Royal M, Jenson M, et al; Topiramate for the Treatment of Neuropathic Pain and Chronic Pain Syndromes: A Retrospective Trial in 61 Patients. Poster Presentation 21st Annual Scientific Meeting of the American Pain Society Mar 14-17 2002, Baltimore, MD
28. Royal M, Jenson M, Bhakta B, Movva V, Ward S; Retrospective Assessment of Frequency of Dosing of Sustained Release Opiate Preparations in Chronic Pain Patients. Poster Presentation 21st Annual Scientific Meeting of the American Pain Society Mar 14-17 2002, Baltimore, MD
29. Ward S, Royal M, Jenson M, et al; Fluoroscopy-guided sacroiliac joint injections with Phenol Ablation for Persistent Sacroiliitis: Pain Practice Volume:2:4(2002-12)
30. Bhakta B, Movva V, Ward S, Jenson M, Royal M; Botulinum Toxin Type B (Myobloc) in the Treatment of Refractory Myofascial Pain. Poster Presentation 21st Annual Scientific Meeting of the American Pain Society Mar 14-17 2002, Baltimore, MD
31. Bhakta B, Movva V, Ward S, Jenson M, Royal M; Intrathecal Ziconotide Effect on Neuropathic Symptoms and Potential for Adjunctive use with Opiates: A Retrospective Review in 25 Patients. Poster Presentation 21st Annual Scientific Meeting of the American Pain Society Mar 14-17 2002, Baltimore, MD
32. Jenson M; Role of Selective Serotonin Reuptake Inhibitors in the Management of Neuropathic Pain. The Pain Clinic. March 2002 Vol8:3, 44-47
33. Jenson M, Royal M, et al; Topiramate for the Treatment of Neuropathic Pain and Chronic Pain Syndromes: An Open Label Trial. American Journal of Pain Management. January 2002Vol 12:1, 16-23.
34. Jenson M, Royal M, et al; American Journal of Pain Management. October 2001Vol 11:4, 125-128. Published in abstract by the Dannemiller Memorial Education Foundation, Analgesia File 2001.
35. Jenson M. Improved Patient Compliance after Trigger Point Injections using 0.9% Sodium Chloride Compared to Bupivacaine 0.25% for Patients with Myofascial Pain Syndrome. The Pain Practitioner, Vol 11.2 Fall 2001
36. Jenson M. Case Study: Vertebral Hemangioma in a Patient with Chronic Pain. Physician Assistant. October 2001 Vol 24:10, 47-48
37. Royal M, Jenson M, et al; Open Label Trial of Oxcarbazepine in Neuropathic Pain. Poster presentation 2nd congress of world institute of pain. Istanbul Turkey June 2001 conference.
38. Jenson M, Royal M. Transdermal Fentanyl in the Treatment of Pain in Cystic Fibrosis Patients. American Journal of Pain Management. July 2001Vol 11:3, 96-99. Published in abstract by the Dannemiller Memorial Education Foundation, Analgesia File 2001.
39. Royal M, Jenson M, et al; Open Label Trial of Oxcarbazepine in Neuropathic Pain. Poster presentation 2nd congress of world institute of pain. Istanbul Turkey June 2001 conference.
40. Royal M, Gunyae I, Jenson M, et al; Botulinum Toxin Type A in the Treatment of Refractory Myofascial Pain. Poster presentation American academy of neurology. May 2001 conference.
41. Jenson M, Royal M. Is Oxcarbazepine an Effective Treatment for Migraine: Two Case Reports? American Journal of Pain Management. April 2001,Vol 11:2, 60-62. Published in abstract by the Dannemiller Memorial Education Foundation, AnalgesiaFile2001.
42. Royal M, Jenson M, et al; Retrospective Study of Efficacy of Radiofrequency Neurolysis for Facet Arthropathy. Poster presentation American academy of pain medicine. Feb 2001 conference.
43. Royal M, Jenson M, et al; Retrospective Study of Efficacy of Tizanidine in the Treatment of Chronic Pain. Poster presentation American academy of pain medicine. Feb 2001 conference.

PHARMACEUTICAL RESEARCH EXPERIENCE: SUB-INVESTIGATOR.

* ANS EON Paddle study 2006
* L105 Endo Pharma A Prospective Randomized, Controlled Trial Evaluating the Safety and Efficacy of LIDODERM( (LIDOCAINE 5 % TRANSDERMAL PATCHES) Compared to Trigger Point Injections in the Treatment of Patients with Low Back Pain After Nonoperated Injury 40 patient comparison study.
* N01087 UCB Pharma A double-blind, randomized, placebo-controlled, parallel-group, 16 week, multicenter trial evaluating the efficacy and safety of levetiracetam 500 mg tablets in bid administration (daily dose ranging from 1000 mg to 3000 mg), in adults (greater than or equal to 18 years of age) suffering from postherpetic neuralgia
* MEM-MD-19 Randomized, Double-Blind Placebo-Controlled, Flexible Dose Study Of The Efficacy And Safety Of Memantine In Comparison To Gabapentin In Patients With Painful diabetic Neuropathy
* MEM-MD-03 A Long-Term Extension Study Evaluating the Safety and Tolerability of four Memantine Dosing Regimens in Patients with Moderate to Severe Dementia of the Alzheimer‘s type
* M03-644 Double-Blind, Fixed Dose, Parallel-Group Comparison of Controlled Release Hydromorphone Hydrocholoride (HCl) vs. Placebo in Subjects with Osteoarthritis
* ELN92045-351 An open-label, long-term, multi-center study of ZICONOTIDE administered Intrathecally,
* CIMA Protocol 099-14 OraVescent(r) Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid-Tolerant Cancer Patients
* ANS C-03-02 occipital stimulator study
* ANS C-02-01 Trunk/limb stimulator study
* Johnson & Johnson Pharmaceuticals, R331333-PAI-2001, " A 4-Week Randomized, Multicenter, Double-Blind, Placebo-and Active-controlled, Parallel-Group, Forced-Titration Phase IIB Study
* Comparing Efficacy and Safety of Ascending Doses of CG5503 Prolonged Release Up to 233 mg BID and Oxycodone Prolonged Release Up To 20mg BID To Placebo In Subjects With Moderate To Severe Chronic Pain Due To Osteoarthritis Of The Knee."
* Elan Pharmaceuticals, Inc. ELN92045-302, "An Open-Label, 3-Week, With Optional Long-Term Extension Phase, Multicenter Study Of The Safety And Efficacy Of Intrathecal Ziconotide (Prialt(r)) For Chronic, Severe Pain When Delivered Via An External Pump."
* Allergan Pharmaceuticals, PETC-9901B, "A Prospective Double-Blind, Randomized Clinical Study Comparing High, Moderate and Low Volume of Injectate per Trigger Point with Botox in the Treatment of Cervical Myofascial Pain."
* Elan Pharmaceuticals, Inc. ELN92045-351, "An Open-Label-Long-Term, Multicenter Study of Ziconotide Administered Intrathecally."
* Elan Pharmaceuticals, Inc. ELN92045-301, "A Phase III Randomized, Double-Blind, Placebo Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain."
* Elan Pharmaceuticals, Inc. ELN92045-352, "An Open-Label, Long-Term, Multicenter Study of Ziconotide Administered Intrathecally."
* Forest Laboratories, Inc., MEM-MD-06 A&B, "A Phase III, Double-Blind Comparison of Memantine and Placebo in the Treatment of Chronic Pain in Patients with Diabetic Neuropathy." * KRONUS/MSP Kadian (r)Faulding 2002 Dosing study.
* Novartis sponsored Diabetic Neuropathy (CTR1476G2301): A Phase III, Multicenter, double-blind, randomized, placebo-control, parallel-group study to evaluate the safety and efficacy of Trileptal(r) in patients with neuropathic pain due to diabetic neuropathy.
* Pharmacia IND# 53,734 2001 Multi-center randomized, double-blind, parallel group, multiple dose comparison of Valdecoxib 40 mg, Sumatriptan 50mg and placebo in patients with moderate or severe acute migraine headache.
* Forest Laboratories, Inc. New York, NY IND# 52,704 2001Evaluation of safety and efficacy of Memantine in the treatment of chronic pain patients with diabetic neuropathy.
* Botulinum toxin for myofascial pain" abstract presented and published with materials at the Interagency Botulinum Research Coordinating Committee annual meeting, Asilomar Conference Center, Pacific Grove, CA. Unrestricted educational grant,
* Elan Pharmaceuticals to study botulinum toxin B in the treatment of low back myofascial pain. * Roxane sponsored Multicenter trial of sustained release Oxycodone in Osteoarthritis
* Anesta sponsored Multicenter trial of Actiq (Fentanyl lozenge) for breakthrough cancer pain
* "Open label trial of Levetiracetam in Neuropathic pain" submitted for poster presentation at the American Pain Society scientific meeting, April 2001.
* "Open label trial of Oxcarbazepine in Neuropathic pain" submitted for poster presentation at the International pain conference Istanbul 2001.
* Janssen Research Foundation FEN-USA-87 study to assess the safety, dose and titration of Duragesic in pediatric subjects with chronic pain requiring opioid therapy.
* Elan Pharmaceuticals 98-022 long-term safety study of intraspinal Ziconotide for refractory chronic pain.
* Elan Pharmaceuticals 98-029 long-term safety study of epidural Ziconotide for refractory chronic pain.
* Allergan Inc. sponsored Multicenter, randomized, placebo controlled trial of botulinum toxin A in chronic low back pain.
* Allergan Inc sponsored Multicenter, randomized trial on injection techniques for cervicothoracic myofascial pain.
* Unrestricted educational grant, Allergan Inc., to study botulinum toxin A volume effects in the treatment of cervicothoracic myofascial pain.
* Unrestricted educational grant, Elan Pharmaceuticals to study botulinum toxin B in the treatment of low back myofascial pain.
* ISIS-4 Study - Fourth International Study of Infarct Survival. Large multi-center study of the effects of oral mononitrate, oral captopril and intravenous magnesium. (1991: V.A. Medical Center, Muskogee, Oklahoma)
* D.I.G. Study - The Captopril-Digoxin multi-center study in patients with mild-moderate heart failure. (1990: V.A. Medical Center, Muskogee, Oklahoma)
* ISIS-3 Study - Third International Study of Infarct Survival. Large multi-center study of efficacy and safety of different thrombolytics with the additional of fibrinolytic agents and aspirin. (1989: V.A. Medical Center, Muskogee, Oklahoma)
* Dapsone Study - Vanderbilt University study of the use of Dapsone as a primary therapy and an adjunct to surgery in Brown Recluse spider bites. (1985: Blanchfield Army Hospital, Ft. Campbell, Kentucky)

LECTURE SERIES

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. - Pfizer Pharmaceuticals

New Treatment for Neuropathic Pain: The Expanding Role of Antiepileptic Drugs. Sponsor UCB Pharma.

New Joint Commission Pain Standards: No More Excuses. - Sponsor Alpharma Faulding Pharmaceuticals

Prescribing of Opiates and Adjunctive Medication in the Treatment of Pain. - Sponsor Alpharma Faulding Pharmaceuticals

Long Acting Opiates in Non-malignant Pain - Sponsor Janssen Pharmaceuticals